On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
A major Western Pacific review led by Byron Perrin and Peter Lazzarini maps the world’s largest regional diabetes-related foot disease burden—and eight practical ways countries can strengthen care.
A multinational team reports strong 14-day reproducibility for the simple ACT neuropathy screen—an important reliability milestone, but not yet a diagnostic-accuracy study.
A Stanford team has taught an algorithm to translate Doppler sounds into clinically meaningful ankle-brachial index ranges—potentially bringing vascular assessment closer to the point of care.
A new systematic review and meta-analysis supports functional moisturizers—particularly urea-containing formulations—for diabetic foot xerosis on intact skin.
Before asking an advanced wound therapy to perform, make sure the Wound OS has been rebooted—and verify that the reset worked.
For generations, bacteremia—especially Staphylococcus aureus bacteremia—has almost reflexively meant prolonged IV therapy. But the evidence base continues to chip away at the idea that the route of administration is itself the treatment. A terrific new multicenter study in Open Forum Infectious Diseases, including our world-class infectious-disease colleagues at LA General Medical Center and the Los... Continue Reading →
Nashville, Tennessee — August 6, 2026 There are few better ways to start a national meeting than looking out at a packed room of mission driven folks at 7:30 in the morning. I had the privilege of chairing and lecturing in the opening session of the 2026 American Podiatric Medical Association Annual Scientific Meeting—The National,... Continue Reading →
Margin-directed antibiotic therapy after surgery for diabetic foot osteomyelitis is appealing, but surgical assessment, histopathology, and microbiology often provide different answers. A new Clinical Infectious Diseases Viewpoint explains why multidisciplinary interpretation and prospective standardization are essential.
A new Diabetes Care registry study shows that Charcot neuro-osteoarthropathy is far more than a local foot disorder. Following diagnosis, nearly nine in ten patients required emergency hospitalization, almost one-third underwent amputation, and only 44% were alive and amputation-free at five years.
Large language models can describe the world. Embodied AI must act in it. The likely progression—from factories, to hospitals, to homes—is a rising test of repeatability, accountability, and trust.
